Skip to main content
Lisa Frenkel, MD, Pediatric Infectious Disease, Seattle, WA

LisaMarieFrenkelMD

Pediatric Infectious Disease Seattle, WA

Professor, Pediatrics, University of Washington School of Medicine

Dr. Frenkel is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Frenkel's full profile

Already have an account?

  • Office

    4800 Sand Point Way NE
    Seattle, WA 98105
    Phone+1 206-987-2000

Education & Training

  • UCLA David Geffen School of Medicine/UCLA Medical Center
    UCLA David Geffen School of Medicine/UCLA Medical CenterResidency, Pediatrics, 1981 - 1987
  • University of Kansas School of Medicine
    University of Kansas School of MedicineClass of 1981

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 1982 - Present
  • WA State Medical License
    WA State Medical License 1994 - 2025
  • NY State Medical License
    NY State Medical License 1992 - 1994
  • American Board of Pediatrics Pediatrics
  • American Board of Pediatrics Pediatric Infectious Diseases

Clinical Trials

Publications & Presentations

PubMed

Press Mentions

  • Seattle Children’s Researchers Discover That Functional COVID-19 Antibodies Are Lost Quickly After Mild Cases
    Seattle Children’s Researchers Discover That Functional COVID-19 Antibodies Are Lost Quickly After Mild CasesMay 27th, 2021
  • Scientist Develops New Way to Test for COVID-19 Antibodies
    Scientist Develops New Way to Test for COVID-19 AntibodiesOctober 23rd, 2020
  • CIDR to Merge with Seattle Children’s, Creating Largest Pediatric Infectious Disease Org in the US
    CIDR to Merge with Seattle Children’s, Creating Largest Pediatric Infectious Disease Org in the USJuly 24th, 2018

Grant Support

  • HIV-1 Evolution In The Female Genital Tract And Trafficking To The BloodNational Institute Of Allergy And Infectious Diseases2011–2012
  • Academic Pediatric Infectious DiseaseEunice Kennedy Shriver National Institute Of Child Health &Human Development2010–2012
  • Viral Determinants Of HIV-1 Transmission In African HeterosexualsNational Institute Of Allergy And Infectious Diseases2010–2011
  • HIV-1 Evolution In The Female Genital Tract And Trafficking To The BloodNational Institute Of Allergy And Infectious Diseases2010
  • Quantification And Dynamics Of HIV-1 Drug Resistant Mutants By PirosequencingNational Institute Of Allergy And Infectious Diseases2009–2010
  • Mechanism/Predictors Of Genital/Rectal HIV Shedding During ART W/Plasma <50c/MlNational Institute Of Allergy And Infectious Diseases2006–2010
  • Reservoirs Of Drug-Resistant HIV-1National Institute Of Allergy And Infectious Diseases2005–2009
  • Pediatric LATE Outcomes (Aids Clinical Trial Group # 219)National Center For Research Resources2006–2007
  • Pactg 1055: Psychiatric Co-Morbidity In Perinatally HIV -Infected ChildrenNational Center For Research Resources2006–2007
  • Assessment Of Alveolar Macrophages As A Reservoir For HIVNational Center For Research Resources2005–2007
  • Etiology Of Mastitis In HIV-1 Infected WomenNational Institute Of Allergy And Infectious Diseases2005–2006
  • Immunization By HIV Exposure During ChemoprophylaxisEunice Kennedy Shriver National Institute Of Child Health &Human Development2001–2006
  • Pediatric LATE Outcomes AIDS Clinical Trial Group # 219National Center For Research Resources2005
  • Reservoirs Of Drug-Resistant HIV-1National Institute Of Allergy And Infectious Diseases2004
  • Pediatric LATE Outcomes (Actg 219)National Center For Research Resources2004
  • Prevention Of HIV Resistance To Nevirapine In PregnancyFogarty International Center2001–2003
  • HIV Shedding And EvolutionEunice Kennedy Shriver National Institute Of Child Health &Human Development2002
  • Pediatric LATE Outcome ProtocolNational Center For Research Resources2000–2002
  • Therapy Effects On HIV 1 Population Dynamics In ChildrenEunice Kennedy Shriver National Institute Of Child Health &Human Development1998–2002
  • AIDS Clinical TrialsNational Institute Of Allergy And Infectious Diseases1994–2002
  • HIV 1 Dynamics &Resistance In Children Given Highly Active AntiretroNational Center For Research Resources1999–2000
  • Phase II Evaluation On ZDV 3TC VS D4T Ritonavir VS ZDV 3TC RitonavirNational Center For Research Resources1998–2000
  • Pediatric LATE Outcome Protocol--Actg219National Center For Research Resources1998–2000
  • Immunizing By Mucosal SIV Exposure During RT InhibitionNational Center For Research Resources1998–1999
  • A Study Of Hivig In Slowing Progression Of HIV Disease In HIV Infected ChildrenNational Center For Research Resources1997–1999
  • Use Of Hivig For The Prevention Of Maternal-Fetal HIV TransmissionNational Center For Research Resources1996–1999